Movement Alert｜Spyre Therapeutics Falls 14.76% in Regular Trading, Trading at $85.98

Market Focus06-24

On June 24, Spyre Therapeutics fell 14.76% in regular trading, trading at $85.98/share, with Turnover of $40.79 million.

Within the Biotechnology sector where Spyre Therapeutics belongs, sector performance was mixed. Among individual stocks, Absci Corporation up 38.39%, Apogee Therapeutics up 0.01%, AbbVie up 0.36%, Argenx SE up 2.32%, uniQure NV down 2.67%.

Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients living with inflammatory bowel disease (IBD). Its pipeline includes SPY001 targeting a4β7 integrin, SPY002 targeting TL1A, and combination therapies, as well as anti-IL-23 programs.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159242098?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 21:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159242098","market":"us","top_or_hot":-1,"title":"Movement Alert｜Spyre Therapeutics Falls 14.76% in Regular Trading, Trading at $85.98","media":"Market Focus","content":"<p><p>On June 24, Spyre Therapeutics fell 14.76% in regular trading, trading at $85.98/share, with Turnover of $40.79 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, sector performance was mixed. Among individual stocks, Absci Corporation up 38.39%, Apogee Therapeutics up 0.01%, AbbVie up 0.36%, Argenx SE up 2.32%, uniQure NV down 2.67%.</p><p>Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients living with inflammatory bowel disease (IBD). Its pipeline includes SPY001 targeting a4β7 integrin, SPY002 targeting TL1A, and combination therapies, as well as anti-IL-23 programs.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Spyre Therapeutics Falls 14.76% in Regular Trading, Trading at $85.98</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Spyre Therapeutics Falls 14.76% in Regular Trading, Trading at $85.98\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 24, Spyre Therapeutics fell 14.76% in regular trading, trading at $85.98/share, with Turnover of $40.79 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, sector performance was mixed. Among individual stocks, Absci Corporation up 38.39%, Apogee Therapeutics up 0.01%, AbbVie up 0.36%, Argenx SE up 2.32%, uniQure NV down 2.67%.</p><p>Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients living with inflammatory bowel disease (IBD). Its pipeline includes SPY001 targeting a4β7 integrin, SPY002 targeting TL1A, and combination therapies, as well as anti-IL-23 programs.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1159242098","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159242098","pubTimestamp":1782308336,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 24, Spyre Therapeutics fell 14.76% in regular trading, trading at $85.98/share, with Turnover of $40.79 million.Within the Biotechnology sector where Spyre Therapeutics belongs, sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC"},"translate_title":"动向提示|Spyre Therapeutics常规交易下跌14.76%，报85.98美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":1},"content_text":"On June 24, Spyre Therapeutics fell 14.76% in regular trading, trading at $85.98/share, with Turnover of $40.79 million.Within the Biotechnology sector where Spyre Therapeutics belongs, sector performance was mixed. Among individual stocks, Absci Corporation up 38.39%, Apogee Therapeutics up 0.01%, AbbVie up 0.36%, Argenx SE up 2.32%, uniQure NV down 2.67%.Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients living with inflammatory bowel disease (IBD). Its pipeline includes SPY001 targeting a4β7 integrin, SPY002 targeting TL1A, and combination therapies, as well as anti-IL-23 programs.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159242098","isCrawlerRequest":true}